title: Management of Hyperleukocytosis.
abstract: Hyperleukocytosis has a high morbidity index. The involvement of the respiratory or central nervous system and the metabolic derangements accompanying tumor lysis are responsible for early mortality. Standard care for acute hyperleukocytosis must include cytoreduction, proper supportive care, and prevention of tumor lysis. Hydration, alkalization, allopurinol, or urate oxidase should be started immediately. In patients with low platelet count of less than 20,000/mm(3), platelet transfusions should be given to prevent cerebral hemorrhage, as platelets do not add substantially to blood viscosity. Packed red blood cells must be given with caution as they can significantly increase blood viscosity. If the patient is hemodynamically stable, packed red transfusions should be planned when the hemoglobin level is less than 7-8 g/dl, avoiding post-transfusional levels above 10 g/dl. Coagulation abnormalities should be corrected. Leukapheresis has been advocated to correct metabolic abnormalities and to decrease viscosity by reducing the peripheral white blood count. However, leukapheresis may fail to decrease the leukocyte count substantially or may achieve only a transient tumor bulk reduction. The procedure is generally well tolerated but can involve problems such as the need for anticoagulation or difficulty of access, and limited availability in many institutions.Specific antileukemic therapy must be initiated as soon as life-threatening complications have been corrected as it remains the first-line treatment of hyperleukocytosis.
authors.affiliation: Division of Pediatric Oncology, A. Gemelli Hospital, Catholic University of Rome, Largo A. Gemelli 8, 00168, Rome, Italy. ruggiero@rm.unicatt.it.
authors.forename: Antonio
authors.initials: A
authors.lastname: Ruggiero
authors.affiliation: Division of Pediatric Oncology, A. Gemelli Hospital, Catholic University of Rome, Largo A. Gemelli 8, 00168, Rome, Italy.
authors.forename: Daniela
authors.initials: D
authors.lastname: Rizzo
authors.affiliation: Division of Pediatric Oncology, A. Gemelli Hospital, Catholic University of Rome, Largo A. Gemelli 8, 00168, Rome, Italy.
authors.forename: Maria
authors.initials: M
authors.lastname: Amato
authors.affiliation: Division of Pediatric Oncology, A. Gemelli Hospital, Catholic University of Rome, Largo A. Gemelli 8, 00168, Rome, Italy.
authors.forename: Riccardo
authors.initials: R
authors.lastname: Riccardi
mesh_terms: D001778:Blood Coagulation Disorders / Q000517:prevention & control; D005440:Fluid Therapy; D006801:Humans; D007937:Leukapheresis; D007938:Leukemia / Q000150:complications*; D007958:Leukocyte Count; D007964:Leukocytosis / Q000628:therapy*; D011379:Prognosis; D015275:Tumor Lysis Syndrome / Q000517:prevention & control
keywords: Acute leukemia; Alkalization; Allopurinol; Hydration; Hyperleukocytosis; Leukapheresis; Rasburicase
references.citation: Clin Appl Thromb Hemost. 2007 Jul;13(3):292-8
references.pmid: 17636191
references.citation: Cancer Control. 2015 Jan;22(1):60-78
references.pmid: 25504280
references.citation: J Pediatr Hematol Oncol. 1996 Aug;18(3):327-30
references.pmid: 8689355
references.citation: Semin Thromb Hemost. 2007 Jun;33(4):350-4
references.pmid: 17525892
references.citation: Eur J Clin Microbiol Infect Dis. 2000 Feb;19(2):77-88
references.pmid: 10746492
references.citation: J Clin Oncol. 2008 Jun 1;26(16):2767-78
references.pmid: 18509186
references.citation: Blood. 2001 Apr 1;97(7):2121-9
references.pmid: 11264180
references.citation: J Clin Oncol. 1987 Sep;5(9):1364-72
references.pmid: 3625254
references.citation: Br J Haematol. 2015 Mar;168(5):646-53
references.pmid: 25312977
references.citation: J Clin Oncol. 1989 Oct;7(10):1528-32
references.pmid: 2778482
references.citation: Hematol Oncol Clin North Am. 1993 Feb;7(1):161-75
references.pmid: 8449857
references.citation: Best Pract Res Clin Haematol. 2003 Sep;16(3):419-32
references.pmid: 12935960
references.citation: J Clin Invest. 1973 Feb;52(2):350-8
references.pmid: 4509637
references.citation: Blood. 1999 Apr 15;93(8):2730-7
references.pmid: 10194453
references.citation: Leuk Lymphoma. 2001 Jun;42(1-2):67-73
references.pmid: 11699223
references.citation: Am J Hematol. 1996 Mar;51(3):250
references.pmid: 8619415
references.citation: Int J Hematol. 2009 Jul;90(1):87-90
references.pmid: 19466507
references.citation: Transfusion. 1989 Feb;29(2):124-7
references.pmid: 2919422
references.citation: Ther Apher Dial. 2003 Apr;7(2):209-14
references.pmid: 12918945
references.citation: Blood. 2015 May 21;125(21):3246-52
references.pmid: 25778528
references.citation: Ther Apher Dial. 2010 Feb;14(1):52-73
references.pmid: 20438520
references.citation: J Clin Oncol. 2011 Sep 10;29(26):e725-6
references.pmid: 21825265
references.citation: Pediatr Blood Cancer. 2008 Jul;51(1):135-7
references.pmid: 18383153
references.citation: Br J Haematol. 2009 Apr;145(1):24-33
references.pmid: 19222477
references.citation: J Clin Oncol. 1988 Sep;6(9):1425-32
references.pmid: 3166486
references.citation: J Child Neurol. 2008 Nov;23(11):1347-52
references.pmid: 18984849
references.citation: Br J Haematol. 1997 Aug;98(2):433-6
references.pmid: 9266944
references.citation: J Cell Biochem. 2013 Mar;114(3):551-7
references.pmid: 22991072
references.citation: N Engl J Med. 2009 Jun 25;360(26):2730-41
references.pmid: 19553647
references.citation: Haematologica. 2008 Dec;93(12):1877-85
references.pmid: 18838473
references.citation: Blood Rev. 2012 May;26(3):117-22
references.pmid: 22364832
references.citation: Adv Ther. 2011 Aug;28(8):684-97
references.pmid: 21779956
references.citation: Medicine (Baltimore). 1974 Nov;53(6):463-78
references.pmid: 4530890
references.citation: Blood. 1971 Sep;38(3):299-301
references.pmid: 5289281
references.citation: Leuk Lymphoma. 2000 Sep;39(1-2):1-18
references.pmid: 10975379
references.citation: J Clin Oncol. 1985 Dec;3(12):1590-5
references.pmid: 3864942
references.citation: Ther Apher. 2002 Feb;6(1):15-23
references.pmid: 11886572
references.citation: Leuk Res. 2014 Apr;38(4):460-8
references.pmid: 24472688
references.citation: J Formos Med Assoc. 2014 Nov;113(11):833-8
references.pmid: 24534017
references.citation: J Clin Oncol. 1994 Dec;12(12):2621-9
references.pmid: 7989937
references.citation: Br J Haematol. 2015 Jun;169(5):661-71
references.pmid: 25876990
references.citation: J Clin Invest. 1977 May;59(5):786-93
references.pmid: 16037
references.citation: Proc Natl Acad Sci U S A. 1992 Nov 1;89(21):9991-5
references.pmid: 1279685